Form 8-K - Current report:
SEC Accession No. 0001213900-13-005461
Filing Date
2013-09-30
Accepted
2013-09-30 16:43:19
Documents
1
Period of Report
2013-09-25
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k092513_actiniumpharma.htm 8-K 24422
  Complete submission text file 0001213900-13-005461.txt   25558
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52446 | Film No.: 131123746
SIC: 6770 Blank Checks